Drug intelligence / Profile preview

Essiac tea

Development stage
Unknown
Lead developer
Essiac Products
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Essiac tea is a popular herbal tea mixture promoted as an alternative treatment for cancer and other illnesses. Originally developed in the 1920s by Canadian nurse Rene Caisse (who named the tea by spelling her last name backwards), the classic formulation consists of four primary botanical ingredients: burdock root (*Arctium lappa*), sheep sorrel (*Rumex acetosella*), slippery elm bark (*Ulmus rubra*), and Indian rhubarb root (*Rheum officinale*). A modified eight-herb version, known as Flor Essence, also includes watercress, blessed thistle, red clover, and kelp. Despite widespread claims of its anticancer, immune-stimulating, and detoxifying properties, extensive laboratory and animal testing by organizations such as the National Cancer Institute (NCI) and Memorial Sloan Kettering Cancer Center have shown no clear evidence of anticancer efficacy. In fact, some in vitro studies suggest it may stimulate the growth of breast cancer cells. Essiac tea is marketed globally as a dietary supplement rather than an approved pharmaceutical drug.

Brand names
EssiacFlor Essence
Other names
Burdock FormulaCaisse's teaOjibwa teaRene Caisse's Essiac TeaRene Caisse's Original Herbal Tea Remedy

Beyond the preview

Go deeper on Essiac tea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Essiac tea.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call